Navigation Links
MDs' reactions to pharma marketing influenced by brand, side effects: Management Insights
Date:12/10/2007

A study of pharmaceutical companies marketing to physicians shows that doctors are most influenced by brand preference and marketing that addresses the problems of drugs with many side effects, according to the Management Insights feature in the current issue of Management Science, the flagship journal of the Institute for Operations Research and the Management Sciences (INFORMS).

Management Insights, a regular feature of the journal, is a digest of important research in business, management, operations research, and management science. It appears in every issue of the monthly journal.

The Debate on Influencing Doctors Decisions: Are Drug Characteristics the Missing Link? is by Sriram Venkataraman of Emory University and Stefan Stremersch of Duke University.

Decision making by physicians on patients treatment has come under increased public scrutiny, with debate on the effects of marketing actions of pharmaceutical firms toward physicians and their impact on physician prescription behavior. Some scholars find a strong and positive influence of marketing actions, some find only moderate effects, and others even find negative effects.

Debate is also mounting on the role of other influencers (such as patient requests) in physician decision making, both on prescriptions and sample dispensing.

In their Management Science paper, Venkataraman and Stremersch argue that one factor that may tip the balance in this debate is the role of drug characteristics, such as a drugs effectiveness and a drugs side effects. Using a unique data set, they show that marketing effortsoperationalized as detailing and symposium meetings of firms to physiciansand patient requests do affect physician decision making differentially across brands.

They also find that the responsiveness of physicians decision making to marketing efforts and patient requests depends upon the drugs effectiveness and side effects.

The current issue of Management Insights is available at http://mansci.journal.informs.org/cgi/reprint/53/11/iv. The full papers associated with the Insights are available to Management Science subscribers. Individual papers can be purchased at http://institutions.informs.org. Additional issues of Management Insights can be accessed at http://mansci.pubs/informs/org/.

The Insights in the current issue are:

  • Managerial Turnover and Strategic Change by Dirk Sliwka
  • Choosing Among Living-Donor and Cadaveric Livers by Oguzhan Alagoz, Lisa M. Maillart, Andrew J. Schaefer, Mark S. Roberts
  • Template Use and the Effectiveness of Knowledge Transfer by Robert J. Jensen, Gabriel Szulanski
  • Coherence and Consistency of Investors Probability Judgments by David V. Budescu, Ning Du
  • Probability Elicitation, Scoring Rules, and Competition Among Forecasters by Kenneth C. Lichtendahl Jr., Robert L. Winkler
  • Simulation of Coherent Risk Measures Based on Generalized Scenarios by Vadim Lesnevski, Barry L. Nelson, Jeremy Staum
  • The Effects of Statistical Information on Risk and Ambiguity Attitudes, and on Rational Insurance Decisions by Peter P. Wakker, Danille R. M. Timmermans, Irma Machielse
  • Final-Offer Arbitration and Risk Aversion in Bargaining by Eran Hanany, D. Marc Kilgour, Yigal Gerchak
  • Convertible Bond Underpricing: Renegotiable Covenants, Seasoning, and Convergence by Alex W. H. Chan, Nai-fu Chen
  • Optimal Feature Advertising Design Under Competitive Clutter by Rik Pieters, Michel Wedel, Jie Zhang


'/>"/>

Contact: Barry List
barry.list@informs.org
443-757-3560
Institute for Operations Research and the Management Sciences
Source:Eurekalert

Related medicine news :

1. London School of Hygiene to play key role in global collaboration on adverse drug reactions
2. DOCTORS OPPOSE MARYLAND VACCINE ROUNDUP: Expect Dangerous Reactions When Children Are Treated Like Cattle
3. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
4. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
5. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
10. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
11. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... Beanfields, PBC, makers ... partnering with college students at University of Colorado in Boulder to create new ... campaigns class in the School of Journalism, who selected Beanfields as the brand ...
(Date:5/2/2016)... ... May 02, 2016 , ... In honor of National Physical Fitness ... to people who share their fitness journey on social media. , The foot ... will award a $100 product voucher each week during May to one winner. , ...
(Date:5/2/2016)... ... , ... East Los Angeles dentist , Dr. Ramin Assili, is now ... receive any dental extraction treatment for $40 off the regular price. This promotion cannot ... lower price, patients can more easily afford extractions to eliminate teeth that are damaged ...
(Date:5/2/2016)... County, CA (PRWEB) , ... May 02, 2016 , ... ... now linking dental health and cognitive decline. According to the research, which was published ... have some degree of cognitive decline, and about 5.4 million Americans have Alzheimer’s disease. ...
(Date:5/2/2016)... ... 02, 2016 , ... Pregnancy Awareness Month offers a great time to get ... “If you are ready to have a baby, it’s best to get started before ... is your Personal Conception & Pregnancy Organizer, written for women who plan on becoming ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... , April 28, 2016 ... development of innovative peptide and gene-based immunotherapeutics and vaccines for ... will be presenting at the 3rd Annual Growth Capital ... 5 th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: